Correlation Between Anavex Life and Virpax Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Anavex Life and Virpax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anavex Life and Virpax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anavex Life Sciences and Virpax Pharmaceuticals, you can compare the effects of market volatilities on Anavex Life and Virpax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anavex Life with a short position of Virpax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anavex Life and Virpax Pharmaceuticals.

Diversification Opportunities for Anavex Life and Virpax Pharmaceuticals

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Anavex and Virpax is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Anavex Life Sciences and Virpax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virpax Pharmaceuticals and Anavex Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anavex Life Sciences are associated (or correlated) with Virpax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virpax Pharmaceuticals has no effect on the direction of Anavex Life i.e., Anavex Life and Virpax Pharmaceuticals go up and down completely randomly.

Pair Corralation between Anavex Life and Virpax Pharmaceuticals

Given the investment horizon of 90 days Anavex Life Sciences is expected to generate 0.61 times more return on investment than Virpax Pharmaceuticals. However, Anavex Life Sciences is 1.63 times less risky than Virpax Pharmaceuticals. It trades about 0.14 of its potential returns per unit of risk. Virpax Pharmaceuticals is currently generating about -0.08 per unit of risk. If you would invest  570.00  in Anavex Life Sciences on September 15, 2024 and sell it today you would earn a total of  260.00  from holding Anavex Life Sciences or generate 45.61% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Anavex Life Sciences  vs.  Virpax Pharmaceuticals

 Performance 
       Timeline  
Anavex Life Sciences 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Anavex Life Sciences are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Anavex Life disclosed solid returns over the last few months and may actually be approaching a breakup point.
Virpax Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Virpax Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Anavex Life and Virpax Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Anavex Life and Virpax Pharmaceuticals

The main advantage of trading using opposite Anavex Life and Virpax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anavex Life position performs unexpectedly, Virpax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virpax Pharmaceuticals will offset losses from the drop in Virpax Pharmaceuticals' long position.
The idea behind Anavex Life Sciences and Virpax Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
CEOs Directory
Screen CEOs from public companies around the world
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins